Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halima el Omri

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Bioinformation|April 6, 2018
Current Opinions on Chemoresistance: An OverviewSaba Hasan, Ruba Taha, Halima El Omri
Clinical Case Reports|November 29, 2023
Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemiaNancy Kassem, Awni Alshurafa, Hesham Elsabah, et al.
Hematology (Amsterdam, Netherlands)|September 4, 2023
Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literatureAbdelaziz Mohamed, Mohammed Alkhatib, Awni Alshurafa, et al.
Ejhaem|July 18, 2022
Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature reviewTheresa Paul, Anil Yousaf Ellahie, Yazan Salah Almohtasib, et al.
Frontiers in Oncology|July 25, 2024
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature reviewHesham Elsabah, Rola Ghasoub, Halima El Omri, et al.
La Tunisie Medicale|January 22, 2003
[Primary renal non-Hodgkin lymphoma]Halima el Omri, Imen Kraiem, Habib Amara, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Prediction of Multiple Clinical Complications in Cancer Patients to Ensure Hospital Preparedness and Improved Cancer CareRegina Padmanabhan, Adel Elomri, Ruba Yasin Taha, et al.
Annales De Biologie Clinique|December 5, 2012
Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacsImen Kraiem, Samira Hadhri, Halima El Omri, et al.
Case Reports in Hematology|November 28, 2019
Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and ReviewDina Sameh Soliman, Ahmad Al-Sabbagh, Feryal Ibrahim, et al.
Studies in Health Technology and Informatics|June 30, 2023
Machine Learning for Diagnosis and Screening of Chronic Lymphocytic Leukemia Using Routine Complete Blood Count (CBC) ResultsRegina Padmanabhan, Yousra El Alaoui, Adel Elomri, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Bioinformation|April 6, 2018
Current Opinions on Chemoresistance: An OverviewSaba Hasan, Ruba Taha, Halima El Omri
Clinical Case Reports|November 29, 2023
Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemiaNancy Kassem, Awni Alshurafa, Hesham Elsabah, et al.
Hematology (Amsterdam, Netherlands)|September 4, 2023
Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literatureAbdelaziz Mohamed, Mohammed Alkhatib, Awni Alshurafa, et al.
Ejhaem|July 18, 2022
Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature reviewTheresa Paul, Anil Yousaf Ellahie, Yazan Salah Almohtasib, et al.
Frontiers in Oncology|July 25, 2024
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature reviewHesham Elsabah, Rola Ghasoub, Halima El Omri, et al.
La Tunisie Medicale|January 22, 2003
[Primary renal non-Hodgkin lymphoma]Halima el Omri, Imen Kraiem, Habib Amara, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Prediction of Multiple Clinical Complications in Cancer Patients to Ensure Hospital Preparedness and Improved Cancer CareRegina Padmanabhan, Adel Elomri, Ruba Yasin Taha, et al.
Annales De Biologie Clinique|December 5, 2012
Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacsImen Kraiem, Samira Hadhri, Halima El Omri, et al.
Case Reports in Hematology|November 28, 2019
Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and ReviewDina Sameh Soliman, Ahmad Al-Sabbagh, Feryal Ibrahim, et al.
Studies in Health Technology and Informatics|June 30, 2023
Machine Learning for Diagnosis and Screening of Chronic Lymphocytic Leukemia Using Routine Complete Blood Count (CBC) ResultsRegina Padmanabhan, Yousra El Alaoui, Adel Elomri, et al.
Pageof 5